Search

Search results

Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Is Less More?

… Text Figures & Tables References Article Duration of Dual Antiplatelet Therapy After Percutaneous Coronary … of aspirin and a P2Y 12 in hibitor is prescribed in the treatment of acute coronary syndrome (ACS) or following …

Type:

Article

Controversies in Antiplatelet and Anticoagulation Therapy in Patients Presenting with Acute Coronary Syndrome

… Text Figures & Tables References Article Controversies in Antiplatelet and Anticoagulation Therapy in Patients … (3) transition between antiplatelets; (4) duration of dual antiplatelet therapy; and (5) management of patients on … the index event, recurrent ischemic events after initial treatment, and complications from guideline-directed …

Type:

Article

Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention

… Figures & Tables References Article Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary … use of more potent agents or prolonged dual antiplatelet treatment (DAPT) on atherothrombotic complications are …

Type:

Article

Guest Editorial: A Brave New World for Non-vitamin K Antagonist Oral Anticoagulants: Have We seen the Last of Warfarin?

… K antagonist oral anticoagulants (NVKA) for antithrombotic treatment has freed patients with atrial fibrillation (AF) … the physician is challenged with decisions regarding which antiplatelet regimen to administer. The open-label, … with AF treated with PCI. At 1-year follow-up both dual and triple therapy with rivaroxaban were superior to …

Type:

Article

TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy Versus Ticagrelor Plus Aspirin Beginning at 3 Months in High-risk Patients Undergoing Percutaneous Coronary Intervention

… P2Y 12 inhibitor-based monotherapy after a short period of dual antiplatelet therapy is emerging as a plausible strategy to … decrease bleeding events in high-risk patients receiving dual antiplatelet therapy after percutaneous coronary …

Type:

Article

Dual Anti-platelet Therapy after Coronary Stenting: Rationale for Personalized Duration of Therapy

… Metrics Article Text Figures & Tables References Article Dual Anti-platelet Therapy after Coronary Stenting: Rationale … Regiment: Safety and Efficacy of 6 Months Dual Antiplatelet Therapy after Drug-Eluting Stenting (ISAR-SAFE) … For example, in the Prolonging Dual Antiplatelet Treatment After Grading Stent-induced Intimal Hyperplasia …

Type:

Article

ACC 2020: Update from the TWILIGHT Study

… ? [Angiolillo] As a way of background, we know that a dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is … aspirin and ticagrelor, and patients who were compliant to treatment and who had not experienced an adverse event, …

Type:

Video

Between a Rock and a Hard Place: How to Use Antithrombotics in Patients Undergoing Transcatheter Aortic Valve Replacement

… therapy in patients undergoing TAVR, studies evaluating antiplatelet regimens, and studies evaluating the use of … in a study by Nuhrenberg et al. looking at the effects of dual anti-platelet therapy (DAPT) on the prevention of … amplification of the benefits associated with this treatment. Given the lack of randomization of these studies, …

Type:

Article

Attending to Links in the Safety Chain for Drug-Eluting Stents

… thrombosis in this study was premature discontinuation of antiplatelet therapy (hazard ratio (HR) 89.78, p …

Type:

Article

TCT Connect 2020: The XIENCE 90/28 Trials

… XIENCE 90/28 evaluated the safety of 3-month and 1 month dual antiplatelet therapy (DAPT) in subjects at high risk of … 6. How these findings should impact future research and treatment? 7. Should these results have any impact on …

Type:

Video